miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes

Experimental and Molecular Medicine

Volumn 47, Issue 10, 2015, Pages

  Makki, Mohammad Shahidul ^a   Haqqi, Tariq M ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 139; PROTEIN MCPIP1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; IL6 PROTEIN, HUMAN; MIRN139 MICRORNA, HUMAN; RIBONUCLEASE; TRANSCRIPTION FACTOR; ZC3H12A PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE OSTEOARTHRITIS; LUCIFERASE ASSAY; MALE; MOLECULAR INTERACTION; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; UPREGULATION;

3' UNTRANSLATED REGIONS; AGED; APOPTOSIS; CHONDROCYTES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MALE; MICRORNAS; MIDDLE AGED; OSTEOARTHRITIS; RIBONUCLEASES; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84955752293     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2015.66     Document Type: Article

References (49)

1. Goldring MB, Marcu KB. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med 2012; 18: 109-118.
2. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004; 427: S27-S36.
3. Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol 2013; 146: 185-196.
4. White EJ, Brewer G, Wilson GM. Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta 2013; 1829: 680-688.
5. Iwasaki H, Takeuchi O, Teraguchi S, Matsushita K, Uehata T, Kuniyoshi K et al. The IkappaB kinase complex regulates the stability of cytokineencoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat Immunol 2011; 12: 1167-1175.
6. Mizgalska D, Wegrzyn P, Murzyn K, Kasza A, Koj A, Jura J et al. Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA. FEBS J 2009; 276: 7386-7399.
7. Makki MS, Haseeb A, Haqqi TM. Micro RNA-9 (miR-9) promote IL-6 expression by targeting MCPIP1 in IL-1β-stimulated human chondrocytes. Ind J Rheumatol 2014; 9: S4.
8. Makki MS, Haseeb A, Haqqi TM. MCPIP1 regulates the expression of interleukin-6 in human osteoarthritis chondrocytes. Osteoarthr Cartil 2014; 22: S166.
9. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 2009; 458: 1185-1190.
10. Zhou L, Azfer A, Niu J, Graham S, Choudhury M, Adamski FM et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 2006; 98: 1177-1185.
11. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005; 310: 1817-1821.
12. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
13. Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, Haqqi TM. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010; 62: 1361-1371.
14. Swingler TE, Wheeler G, Carmont V, Elliott HR, Barter MJ, Abu-Elmagd M et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 2012; 64: 1909-1919.
15. Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthr Cartil 2009; 17: 464-472.
16. Kobayashi T, Lu J, Cobb BS, Rodda SJ, McMahon AP, Schipani E et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 2008; 105: 1949-1954.
17. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010; 24: 1173-1185.
18. Miyaki S, Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012; 8: 543-552.
19. Akhtar N, Makki MS, TM Haqqi. MicroRNA-602 and MicroRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes. Arthritis Rheumatol 2015; 67: 423-434.
20. Makki MS, Haseeb A, Haqqi TM. MicroRNA-9 promotes IL-6 expression by inhibiting MCPIP1 expression in IL-1β-stimulated human chondrocytes. Arthritis Rheumatol (e-pub ahead of print 27 April 2015; doi:10.1002/ art.39173).
21. Haseeb A, Makki MS, Haqqi TM. Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, alpha-Ketoglutarate (alpha-KG), and DNA hydroxymethylation levels by interleukin-1beta in primary human chondrocytes. J Biol Chem 2014; 289: 6877-6885.
22. Rasheed Z, Akhtar N, Haqqi TM. Pomegranate extract inhibits the interleukin-1beta-induced activation of MKK-3, p38alpha-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res Ther 2010; 12: R195.
23. Rasheed Z, Anbazhagan AN, Akhtar N, Ramamurthy S, Voss FR, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther 2009; 11: R71.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
25. Makki MS, Heinzel T, Englert C. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. Nucleic Acids Res 2008; 36: 4067-4078.
26. Shahidul Makki M, Cristy Ruteshouser E, Huff V. Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target. Exp Cell Res 2013; 319: 612-622.
27. Rousseau J, Garnero P. Biological markers in osteoarthritis. Bone 2012; 51: 265-277.
28. Poree B, Kypriotou M, Chadjichristos C, Beauchef G, Renard E, Legendre F et al. Interleukin-6 (IL-6) and/or soluble IL-6 receptor downregulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem 2008; 283: 4850-4865.
29. Mimata Y, Kamataki A, Oikawa S, Murakami K, Uzuki M, Shimamura T et al. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Int J Rheum Dis 2012; 15: 36-44.
30. Wahlgren J, Maisi P, Sorsa T, Sutinen M, Tervahartiala T, Pirila E et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol 2001; 194: 217-224.
31. Hashizume M, Mihara M. Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production. Osteoarthr Cartil 2009; 17: 1513-1518.
32. Anderson P. Post-transcriptional control of cytokine production. Nat Immunol 2008; 9: 353-359.
33. Zhao W, Liu M, D'Silva NJ, Kirkwood KL. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region. J Interferon Cytokine Res 2011; 31: 629-637.
34. Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, Kuhn LC. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol 2006; 26: 8228-8241.
35. Li M, Cao W, Liu H, Zhang W, Liu X, Cai Z et al. MCPIP1 downregulates IL-2 expression through an ARE-independent pathway. PloS One 2012; 7: e49841.
36. Uehata T, Akira S. mRNA degradation by the endoribonuclease Regnase-1/ ZC3H12a/MCPIP-1. Biochim Biophys Acta 2013; 1829: 708-713.
37. Selcuklu SD, Donoghue MT, Rehmet K, de Souza Gomes M, Fort A, Kovvuru P et al. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem 2012; 287: 29516-29528.
38. Tan X, Wang S, Yang B, Zhu L, Yin B, Chao T et al. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PloS One 2012; 7: e49570.
39. Coolen M, Thieffry D, Drivenes O, Becker TS, Bally-Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors. Dev Cell 2012; 22: 1052-1064.
40. Li RY, Chen LC, Zhang HY, Du WZ, Feng Y, Wang HB et al. MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther 2013; 19: 477-483.
41. Guo H, Hu X, Ge S, Qian G, Zhang J. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol 2012; 44: 1465-1472.
42. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95-98.
43. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998; 41: 1760-1771.
44. Rowan AD, Koshy PJ, Shingleton WD, Degnan BA, Heath JK, Vernallis AB et al. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 2001; 44: 1620-1632.
45. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000; 6: 71-79.
46. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784-788.
47. Huebner JL, Seifer DR, Kraus VB. A longitudinal analysis of serum cytokines in the Hartley guinea pig model of osteoarthritis. Osteoarthr Cartil 2007; 15: 354-356.
48. Toncheva A, Remichkova M, Ikonomova K, Dimitrova P, Ivanovska N. Inflammatory response in patients with active and inactive osteoarthritis. Rheumatol Int 2009; 29: 1197-1203.
49. Ding C, Jones G. Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Rev Recent Clin Trials 2006; 1: 193-200.